glutathione vs l-cysteine Cysteine metabolic circuitries: druggable targets in cancer Structure of cysteine, cystine and
Description
and (2) peptides without FDA approval
10.1016/j.ymben.2014.12.006
ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC
No regulations around that
[DOI] [PubMed] [Google Scholar] 211.Sackesen C., Ercan H., Dizdar E., Soyer O., Gumus P., Tosun B.N., Byktuncer Z., Karabulut E., Besler T., Kalayci O
